FELV VACCINE WITH THE TUMOR-SPECIFIC ANTIGEN FOCMA TO AID IN TUMOR PROTECTION
Helps in preventing persistent viraemia, lymphoid tumors caused by feline leukemia virus (FeLV) and diseases associated with FeLV infection.
Leukocell 2
| Active ingredient | Multiple viral antigen vaccines (FeLV subgroups A, B and C) |
|---|---|
| Indication | For vaccination of healthy cats 9 weeks of age or older as an aid in preventing persistent viremia, lymphoid tumours caused by the feline leukemia virus (FeLV) and diseases associated with FeLV infection. |
| Directions |
|
Description
- Demonstrated efficacy in helping prevent persistent viremia, lymphoid tumors and FeLV-associated diseases.
- A FeLV vaccine with the tumor-specific antigen FOCMA (feline oncornavirus-associated cell membrane antigen) to aid in tumor protection.
- Prepared from a FeLV-transformed lymphoid cell line that releases soluble FeLV particles into cell culture medium, reducing the immunosuppressive effects of fully assembled, inactivated FeLV antigens.
- LEUKOCELL 2 is supported by our Companion Animal Immunization Support Guarantee (ISG).
Directions:
1. General Directions: Shake well. Aseptically administer 1 mL subcutaneously.
2. Primary Vaccination: Healthy cats 9 weeks of age or older should receive 2 doses administered 3-4 weeks apart.
3. Revaccination: Annual revaccination with a single dose is recommended.
